Toward a therapeutic intervention of lissencephaly, we applied a novel calpain inhibitor, SNJ1945. Peri-natal or post-natal treatment with SNJ1945 rescued defective neuronal migration in Lis1+/− mice, impaired behavioral performance and improvement of 18F-FDG uptake. Furthermore, SNJ1945 improved the neural circuit formation and retrograde transport of NFG in Lis1+/− mice. Thus, SNJ1945 is a potential drug for the treatment of human lissencephaly patients.
Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly
S. Toba,Yasuhisa Tamura,Kanako Kumamoto,Masami Yamada,K. Takao,S. Hattori,T. Miyakawa,Y. Kataoka,M. Azuma,K. Hayasaka,Masano Amamoto,K. Tominaga,A. Wynshaw-Boris,H. Wanibuchi,Yuichiro Oka,Makoto Sato,Mitsuhiro Kato,S. Hirotsune
Published 2013 in Scientific Reports
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
Scientific Reports
- Publication date
2013-02-06
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-31 of 31 references · Page 1 of 1
CITED BY
Showing 1-19 of 19 citing papers · Page 1 of 1